Birth control pill

Birth control pill

Too much disclosure of product risks? CBC Television, SOGC, and Diane-35

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Barbara Mintzes
Joel Lexchin
Abby Lippman
Anne Rochon Ford
Publisher: 
Canadian Women's Health Network
Publication Date: 
2003
Publication Place: 
Winnipeg, MB

Criticizes the Society of Obstetricians and Gynaecologists countering of a CBC documentary on the acne treatment Diane-35 (cyproterone/estradiol). Presents information that supports the concerns regarding the safety of Diane-35.

Important safety concerns on the use of Diane-35

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Publisher: 
Health Canada
Publication Date: 
2002
Publication Place: 
Ottawa, ON

Discusses an article regarding important safety concerns on the use of cyproterone acetate (marketed as Diane-35 in Canada, and as Dianette in the United Kingdom).

Notes: 
<p>Includes bibliographical references. needs review</p>

Diane-35 (cyproterone acetate): safety concerns

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Publisher: 
Canadian Medical Association Journal
Publication Date: 
2003
Publication Place: 
Ottawa, ON

Discusses warnings regarding the drug, Diane-35, and the drug's risk of venous thromboembolism. States that Diane-35 should be reserved for temporary use in women with serious acne and should not be used solely as an oral contraceptive.

Available From: 

Contraceptive technology & reproductive health series

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Carol Smith
Publisher: 
Family Health International
Publication Date: 
2003
Publication Place: 
Research Triangle Park, NC

Provides training modules designed to meet the continuing educational needs of family planning practitioners, program managers, and policymakers in resource-constrained settings.

Syndicate content